Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 14 August 2027
- Last conf. stmt
- 31 July 2026
Akcea Therapeutics UK Ltd.
- Incorporated
- 1 August 2016 (10 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Donal Murray
- Owned by
- Ionis Pharmaceuticals Inc.
- Accounts type
- Small
- Region
- South East
- Address
- 1st Floor West Davidson HouseForbury SquareReadingRG1 3EU
Officers 1 active
Officer details are public data from the Companies House register.
Murray, Donal
Director · Appointed 22 December 2023
Irish
Born July 1969 (57)
Officer history (6 former)
22 December 2023
Resigned Pollock, Michael as Director
22 December 2023
Appointed Murray, Donal as Director
29 January 2021
31 March 2020
Appointed Pollock, Michael as Director
31 March 2020
Resigned Jones, Richard Anthony as Director
11 March 2020
18 September 2019
Resigned Boyce, Sarah as Director
18 September 2019
Resigned Goldberg, Jeffrey Marc as Director
31 January 2019
2 June 2018
Appointed Jones, Richard Anthony as Director
2 June 2018
Appointed Boyce, Sarah as Director
2 June 2018
1 August 2016
Appointed Goldberg, Jeffrey Marc as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Ionis Pharmaceuticals Inc.
Corporate entity · Notified 12 October 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporate
Reg. no. 2258177
Former controllers (1)
12 October 2020
Ceased Akcea Therapeutics, Inc. — Owns 75–100% of shares
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →